Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 28-10-2022
The sales moved up 27.64% to Rs. 48803.00 millions for the September 2022 quarter as compared to Rs. 38234.00 millions during the year-ago period.Net Profit for the quarter ended September 2022 zoomed to 148.62% from Rs. 4490.00 millions to Rs. 11163.00  millions.Operating profit surged to 19208.00 millions from the corresponding previous quarter of 8664.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 48803.00 38234.00 27.64 85109.00 72569.00 17.28 144052.00 133491.00 7.91
Other Income 1180.00 1181.00 -0.08 5214.00 3043.00 71.34 4820.00 8011.00 -39.83
PBIDT 19208.00 8664.00 121.70 29037.00 16145.00 79.85 30761.00 39379.00 -21.88
Interest 17.00 111.00 -84.68 115.00 176.00 -34.66 380.00 467.00 -18.63
PBDT 19191.00 8553.00 124.38 28922.00 15969.00 81.11 30381.00 38912.00 -21.92
Depreciation 2262.00 2066.00 9.49 4477.00 4037.00 10.90 8143.00 8350.00 -2.48
PBT 16929.00 6487.00 160.97 24445.00 11932.00 104.87 22238.00 30562.00 -27.24
TAX 5766.00 1997.00 188.73 8287.00 3308.00 150.51 6006.00 8698.00 -30.95
Deferred Tax 2790.00 841.00 231.75 3953.00 1168.00 238.44 2080.00 3297.00 -36.91
PAT 11163.00 4490.00 148.62 16158.00 8624.00 87.36 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 39.36 22.66 73.69 34.12 22.25 53.35 21.35 29.50 -27.61